Publications
Found 51 results
Filters: Author is Seaman, Michael S [Clear All Filters]
Combination therapy with anti-HIV-1 antibodies maintains viral suppression.. Nature. 561(7724):479-484.
.
2018. Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site.. JCI Insight. 3(5)
.
2018. .
2018. Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117.. J Exp Med. 215(9):2311-2324.
.
2018. .
2018. Antibody 10-1074 suppresses viremia in HIV-1-infected individuals.. Nat Med. 23(2):185-191.
.
2017. Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.. Sci Transl Med. 9(406)
.
2017. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.. Sci Transl Med. 9(373):pii:eaa12144.
.
2017. Early antibody therapy can induce long-lasting immunity to SHIV.. Nature. 543(7646):559-563.
.
2017. Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.. Cell. 170(4):637-648.
.
2017. Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail.. Sci Transl Med. 9(408)
.
2017. Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys.. J Virol. 91(16):pii:e00498-17.
.
2017. Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency.. Cell. 165(7):1609-20.
.
2016. .
2016. HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.. Science. 352(6288):997-1001.
.
2016. .
2016. AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.. Nature. 519(7541):87-91.
.
2015. .
2015. .
2015. Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice.. Cell. 161(7):1505-15.
.
2015. Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.. PLoS Pathog. 11(8):e1005110.
.
2015. Intra-Spike Crosslinking Overcomes Antibody Evasion by HIV-1.. Cell. 160(3):433-46.
.
2015. A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo.. PLoS Pathog. 11(10):e1005238.
.
2015. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.. Nature. 522(7557):487-91.
.
2015. Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike.. Cell Rep. 7(3):785-95.
.
2014.